Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5308197016 | Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5308198014 | Empagliflozin 10 mg and linagliptin 5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only empagliflozin and linagliptin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Linagliptin (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Linagliptin (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Empagliflozin | true | Inferred relationship | Some | 2 | |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Empagliflozin | true | Inferred relationship | Some | 2 | |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets